Literature DB >> 10974675

Identification and localization of TBX5 transcription factor during human cardiac morphogenesis.

C J Hatcher1, M M Goldstein, C S Mah, C S Delia, C T Basson.   

Abstract

Mutations in the TBX5 transcription factor gene cause human cardiac malformation in Holt-Oram syndrome. To identify and localize TBX5 during cardiac morphogenesis, we performed immunohistochemical studies of TBX5 protein cardiac expression during human embryogenesis. Specific antibody to human TBX5 was generated in rabbits with a TBX5 synthetic peptide and affinity purification of antiserum. Anti-TBX5 was used in immunohistochemical analyses of human cardiac tissue. In embryonic and adult heart, TBX5 is expressed throughout the epicardium and in cardiomyocyte nuclei in myocardium of all four cardiac chambers. Endocardial expression of TBX5 is only present in left ventricle. Asymmetric left-sided transmyocardial gradients of TBX5 protein expression were observed in embryonic but not adult hearts. Human cardiac expression of TBX5 protein correlates with the cardiac manifestations of Holt-Oram syndrome. TBX5 transmyocardial protein gradients may contribute to normal patterning of the human heart during embryogenesis. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974675     DOI: 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  31 in total

1.  Activation of Notch signaling pathway precedes heart regeneration in zebrafish.

Authors:  Angel Raya; Christopher M Koth; Dirk Büscher; Yasuhiko Kawakami; Tohru Itoh; R Marina Raya; Gabriel Sternik; Huai-Jen Tsai; Concepción Rodríguez-Esteban; Juan Carlos Izpisúa-Belmonte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

Review 2.  Epigenetic mechanisms in cardiac development and disease.

Authors:  Marcus Vallaster; Caroline Dacwag Vallaster; Sean M Wu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-01       Impact factor: 3.848

3.  TBX5 is required for embryonic cardiac cell cycle progression.

Authors:  Sarah C Goetz; Daniel D Brown; Frank L Conlon
Journal:  Development       Date:  2006-05-25       Impact factor: 6.868

4.  Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.

Authors:  Débora Varela; Tatiana Varela; Natércia Conceição; Ângela Ferreira; Nuno Marques; Ana Paula Silva; Pedro Azevedo; Salomé Pereira; Ana Camacho; Ilídio de Jesus; M Leonor Cancela
Journal:  Mol Genet Genomics       Date:  2021-04-17       Impact factor: 3.291

Review 5.  Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 6.  Interplay between cardiac transcription factors and non-coding RNAs in predisposing to atrial fibrillation.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  J Mol Med (Berl)       Date:  2018-05-12       Impact factor: 4.599

7.  A genetic assay of three patients in the same family with Holt-Oram syndrome; a case report.

Authors:  Reza Ebrahimzadeh-Vesal; Seyed Kianush Hosseini; Fereshteh Rezakhanlu; Pupak Derakhshandeh-Peykar
Journal:  Rep Biochem Mol Biol       Date:  2013-10

8.  miR-10a and miR-10b target the 3'-untranslated region of TBX5 to repress its expression.

Authors:  Feng Wang; Xue-Yan Yang; Jian-Yuan Zhao; Li-Wei Yu; Ping Zhang; Wen-Yuan Duan; Mei Chong; Yong-Hao Gui
Journal:  Pediatr Cardiol       Date:  2014-04-09       Impact factor: 1.655

9.  Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.

Authors:  Meenakshi Maitra; Marie K Schluterman; Haley A Nichols; James A Richardson; Cecilia W Lo; Deepak Srivastava; Vidu Garg
Journal:  Dev Biol       Date:  2008-11-20       Impact factor: 3.582

10.  Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice.

Authors:  Mark Veugelers; David Wilkes; Kimberly Burton; Deborah A McDermott; Yan Song; Marsha M Goldstein; Krista La Perle; Carl J Vaughan; Art O'Hagan; Kenneth R Bennett; Beat J Meyer; Eric Legius; Mervi Karttunen; Reijo Norio; Helena Kaariainen; Michael Lavyne; Jean-Philippe Neau; Gert Richter; Kaan Kirali; Alan Farnsworth; Karen Stapleton; Peter Morelli; Yoshinori Takanashi; John-Steven Bamforth; Franz Eitelberger; Irene Noszian; Waldimiro Manfroi; James Powers; Yoshihiko Mochizuki; Tsuneo Imai; Gary T C Ko; Deborah A Driscoll; Elizabeth Goldmuntz; Jay M Edelberg; Amanda Collins; Diana Eccles; Alan D Irvine; G Stanley McKnight; Craig T Basson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.